Marco Taglietti M.D.
Net Worth

Last updated:

What is Marco Taglietti M.D. net worth?

The estimated net worth of Dr. Marco Taglietti M.D. is at least $10,125,593 as of 26 Apr 2022. He owns shares worth $212,893 as insider and has received compensation worth at least $9,912,700 in SCYNEXIS, Inc..

What is the salary of Marco Taglietti M.D.?

Dr. Marco Taglietti M.D. salary is $991,270 per year as Chief Executive Officer, Pres & Director in SCYNEXIS, Inc..

How old is Marco Taglietti M.D.?

Dr. Marco Taglietti M.D. is 65 years old, born in 1960.

What stocks does Marco Taglietti M.D. currently own?

As insider, Dr. Marco Taglietti M.D. owns shares in one company:

Company Title Shares Price per share Total value
SCYNEXIS, Inc. (SCYX) Chief Executive Officer, Pres & Director 272,068 $0.78 $212,893

What does SCYNEXIS, Inc. do?

SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

SCYX logo
SCYX
SCYNEXIS, Inc.
$0.78

Marco Taglietti M.D. insider trading

SCYNEXIS, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 75,000 $3 $225,000
Purchase
Common Stock 40,000 N/A N/A
Purchase
Common Stock 166,667 N/A N/A
Purchase
Common Stock Warrant (right to buy) 166,667 N/A N/A
Purchase
Common Stock 9,500 N/A N/A
Purchase
Common Stock 500 N/A N/A
Purchase
Common Stock 10,015 N/A N/A
Purchase
Common Stock 25,000 N/A N/A
Purchase
Common Stock 25,000 N/A N/A
Purchase
Common stock 25,000 N/A N/A
Purchase
Common Stock 25,000 N/A N/A
Purchase
Common Stock Warrant (right to buy) 120,000 N/A N/A
Purchase
Common Stock 100,000 N/A N/A
Purchase
Common Stock Warrant (right to buy) 120,000 $0.93 $111,000
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 4,993 N/A N/A
Purchase
Common Stock 7 N/A N/A
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 25,000 N/A N/A
Purchase
Common Stock 25,000 N/A N/A
Purchase
Common Stock 100,000 N/A N/A
Purchase
Common Stock Warrant (right to buy) 45,000 N/A N/A
Purchase
Common Stock 6,000 N/A N/A
Purchase
Common Stock 5,500 N/A N/A
Purchase
Common Stock 3,000 N/A N/A
Purchase
Common Stock 4,500 N/A N/A
Purchase
Common Stock 6,000 N/A N/A
Purchase
Common Stock 7,733 N/A N/A
Purchase
Common Stock 15,000 N/A N/A
Purchase
Common Stock 25,000 N/A N/A
Purchase
Common Stock 400 N/A N/A
Purchase
Common Stock 1,867 N/A N/A
Purchase
Common Stock 25,000 N/A N/A
Purchase
Common Stock 25,000 N/A N/A

SCYNEXIS key executives

SCYNEXIS, Inc. executives and other stock owners filed with the SEC: